Inactive Instrument

Craven House Capital PLC Stock London S.E.

Equities

GB00B01TVW49

Investment Management & Fund Operators

End-of-day quote London S.E.
- GBX - Intraday chart for Craven House Capital PLC
Sales 2022 - Sales 2023 - Capitalization 657K
Net income 2022 - Net income 2023 -5M EV / Sales 2022 -
Net cash position 2022 1K Net cash position 2023 4K EV / Sales 2023 -
P/E ratio 2022
-3.93 x
P/E ratio 2023
-0.12 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 65.73%
More Fundamentals * Assessed data
Managers TitleAgeSince
Corporate Secretary - -
Members of the board TitleAgeSince
Chairman 45 10-12-30
Director/Board Member - 11-06-26
Director/Board Member 55 16-02-04
More insiders
Craven House Capital Plc is a United Kingdom-based investment company. The Company’s investing policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-commerce sector. Its investment portfolio comprises Garimon Limited, Stormfjord Limited, BioVitos Medical Limited, Rosedog Limited, and Honeydog Limited. Garimon Limited’s assets comprise ownership of the domain www.magazinos.com, a platform for digital magazine distribution. BioVitos Medical Limited has a license to market a patented heart drug, Succifer. Rosedog Limited is the owner of TV Zinos (www.tvzinos.com), a Website which offers a number of free-to-view television channels. The Company’s investment manager is Desmond Holdings Ltd.
More about the company